Methylation status of the PTEN gene in adenoid cystic carcinoma cells

Molecular Medicine Reports

Volumn 3, Issue 5, 2010, Pages 775-779

  Fan, Xiaoping ^a   Chen, Bin ^b   Xu, Junli ^a   Zhang, Huachang ^a   Deng, Feng ^a   Xiang, Xuerong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

5 aza 2 deoxycytidine; DNA methylation; Methylation specific polymerase chain reaction; PTEN

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; LUCIFERASE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADENOID CYSTIC CARCINOMA; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND; UPREGULATION; WESTERN BLOTTING;

EID: 78049522794     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.337     Document Type: Article

References (21)

1. Chandana SR and Conley BA: Salivary gland cancers: current treatments, molecular characteristics and new therapies. Expert Rev Anticancer Ther 8: 645-652, 2008.
2. Dodd RL and Slevin NJ: Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 42: 759-769, 2006.
3. Glisson B, Colevas AD, Haddad R, Krane J, El-Naggar A, Kies M, Costello R, Summey C, Arquette M, Langer C, Amrein PC and Posner M: HER2 expression in salivary gland carcinomas: dependence on histological subtype. Clin Cancer Res 10: 944-946, 2004.
4. Sequeiros-Santiago G, García-Carracedo D, Fresno MF, Suarez C, Rodrigo JP and Gonzalez MV: Oncogene amplification pattern in adenoid cystic carcinoma of the salivary glands. Oncol Rep 21: 1215-1222, 2009.
5. An J, Sun JY, Yuan Q, Tian HY, Qiu WL, Guo W and Zhao FK: Proteomics analysis of differentially expressed metastasis-associated proteins in adenoid cystic carcinoma cell lines of human salivary gland. Oral Oncol 40: 400-408, 2004.
6. Jia L, Esguerra RL, Tang X, Yin H, Sakamoto K, Okada N and Takagi M: Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma. Pathol 54: 217-723, 2004.
7. Affolter A, Helmbrecht S, Finger S, Hörmann K and Götte K: Altered expression of cell cycle regulators p21, p27, and p53 in tumors of salivary glands and paranasal sinuses. Oncol Rep 13: 1089-1094, 2005.
8. Nordkvist A, Röijer E, Bang G, Gustafsson H, Behrendt M, Ryd W, Thoresen S, Donath K and Stenman G: Expression and mutation patterns of p53 in benign and malignant salivary gland tumors. Int J Oncol 16: 477-483, 2000.
9. Renner O, Blanco-Aparicio C and Carnero A: Genetic modelling of the PTEN/AKT pathway in cancer research. Clin Transl Oncol 10: 618-627, 2008.
10. Zhu Y, Wloch A, Wu Q, Peters C, Pagenstecher A, Bertalanffy H and Sure U: Involvement of PTEN promoter methylation in cerebral cavernous malformations. Stroke 40: 820-826, 2009.
11. Mavros A, Hahn M, Wieland I, Koy S, Koufaki ON, Strelocke K, Koch R, Haroske G, Schackert HK and Eckelt U: Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity. J Oral Pathol Med 31: 270-276, 2002. (Pubitemid 34667678)
12. Shen L and Sun CF: The expression of PTEN and PKB in salivary adenoid cystic carcinoma and its clinical significance. Shanghai Kou Qiang Yi Xue 14: 159-163, 2005.
13. Zhang B and Sun CF: The expression of tumor suppressor gene PTEN protein and focal adhesion kinase in salivary adenoid cystic carcinoma and its significance. Shanghai Kou Qiang Yi Xue 14: 578-581, 2005.
14. Hu TH, Wang CC, Huang CC, Chen CL, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS and Tai MH: Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection. Oncol Rep 18: 1417-1426, 2007.
15. Shin KH, Kim JM, Rho KS, Park KH, Oh JE and Min BM: Inactivation of the PTEN gene by mutation, exonic deletion, and loss of transcript in human oral squamous cell carcinomas. Int J Oncol 21: 997-1001, 2002.
16. Noro R, Gemma A, Miyanaga A, Kosaihira S, Minegishi Y, Nara M, Kokubo Y, Seike M, Kataoka K, Matsuda K, Okano T, Yoshimura A and Kudoh S: PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors. Int J Oncol 31: 1157-1163, 2007.
17. El-Mansi MT and Williams AR: Evaluation of PTEN expression in cervical adenocarcinoma by tissue microarray. Int J Gynecol Cancer 16: 1254-1260, 2006.
18. Tost J: DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Methods Mol Biol 507: 3-20, 2009.
19. Anglim PP, Alonzo TA and Laird-Offringa IA: DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol Cancer 7: 81, 2008.
20. Razin A: CpG methylation, chromatin structure and gene silencing - a three-way connection. EMBO J 17: 4905-4908, 1998.
21. Mund C, Hackanson B, Stresemann C, Lübbert M and Lyko F: Characterization of DNA demethylation effects induced by 5-aza-2′- deoxycytidine in patients with myelodysplastic syndrome. Cancer Res 65: 7086-7090, 2005. (Pubitemid 41161236)